Interestingly, CPT1C overexpression in senescent cells can reverse the phenotype, while CPT1C downregulation recapitulates senescence in diverse cancer cell lines, leading to lower proliferation, migration, and invasion rates, and reduced in vivo tumor growth [14, 20, 21, 27]. Here, CPT1C is linked to cancer.